Biological safety concepts of genetically modified live bacterial vaccines (Q36713988)

15 August 2017

1 reference

title

Biological safety concepts of genetically modified live bacterial vaccines (English)

1 reference

15 August 2017

Joachim Frey

1

1 reference

PubMed ID

17239999

15 August 2017

language of work or name

English

0 references

publication date

5 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

25

1 reference

15 August 2017

30

1 reference

15 August 2017

5598-5605

1 reference

Vaccine delivery to animals

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Systemic Pasteurella haemolytica infection as a rare sequel to avirulent live Pasteurella haemolytica vaccination in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Overview of marker vaccine and differential diagnostic test technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Bacterial infectious disease control by vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Vaccines: current regulatory issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Live oral vaccines against cholera: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Behavior of an Aeromonas hydrophila aroA live vaccine in water microcosms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Cloning and characterisation of the aroA and aroD genes of Shigella dysenteriae type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Development of vaccines for prevention of botulism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Contagious bovine pleuropneumonia (CBPP) caused by vaccine strain T1/44 of Mycoplasma mycoides subsp. mycoides SC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Genomic differences between type strain PG1 and field strains of Mycoplasma mycoides subsp. mycoides small-colony type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Evaluation of an aroA mutant Salmonella typhimurium vaccine in chickens using modified semisolid Rappaport Vassiliadis medium to monitor faecal shedding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Lysogenic conversion by a filamentous phage encoding cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.058

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.11.058

1 reference

15 August 2017

1 reference

PubMed ID

17239999